Abbott and Church & Dwight Stocks Trade Below Fair Value with Discounts up to 23%

Financial analysts have identified significant valuation discounts for Abbott Laboratories (ABT) and Church & Dwight (CHD), positioning them as attractive opportunities for defensive investors. Abbott Laboratories is currently trading at approximately 23% below its estimated fair value, despite its robust fundamental position and market standing. The company maintains a prestigious track record, boasting 54 consecutive years of dividend increases, which appeals to stability-focused portfolios. Similarly, Church & Dwight is seen as undervalued by about 10%, with its current price of $93 trailing a fair value estimate of $104. The consumer goods firm has also demonstrated strong digital growth, with online sales now accounting for 23% of its total global revenue. These valuation gaps emerge as market pressures weigh on defensive stocks, offering potential upside for long-term investors.